## **Core Concept**
Extrapyramidal syndrome (EPS) side effects are associated with medications that affect the extrapyramidal tracts of the brain, which are crucial for movement control. These side effects are commonly seen with the use of antipsychotic drugs, particularly the first-generation (typical) antipsychotics. The underlying principle involves the blockade of dopamine receptors, specifically D2 receptors, in the striatum.

## **Why the Correct Answer is Right**
The correct answer, , is right because haloperidol is a typical (first-generation) antipsychotic known for its high potency and strong affinity for dopamine D2 receptors. By blocking these receptors, haloperidol can cause EPS side effects, which include dystonia, parkinsonism, akathisia, and tardive dyskinesia. This is due to the imbalance it creates in the dopaminergic pathways within the basal ganglia.

## **Why Each Wrong Option is Incorrect**
* **Option A:** - This option is incorrect because clozapine is an atypical (second-generation) antipsychotic with a lower propensity to cause EPS. It has a different pharmacological profile, with a lower affinity for D2 receptors and a higher affinity for serotonin receptors, which contributes to its lower risk of EPS.
* **Option B:** - This option is incorrect because escitalopram is an SSRI (selective serotonin reuptake inhibitor) used primarily as an antidepressant. SSRIs do not typically cause EPS as they primarily affect serotonin reuptake and do not significantly interact with dopamine receptors in a way that would lead to EPS.
* **Option C:** - This option is incorrect because risperidone, although it can cause EPS, is an atypical antipsychotic. It has a lower risk of EPS compared to typical antipsychotics like haloperidol, primarily due to its lower D2 receptor occupancy at therapeutic doses.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that the risk of EPS is significantly higher with typical antipsychotics (e.g., haloperidol) compared to atypical antipsychotics. This is a critical consideration in the management of psychosis, especially in patients with schizophrenia or other conditions requiring long-term antipsychotic therapy.

## **Correct Answer: .**